Levamisole

Human medicines European public assessment report (EPAR): Emtricitabine / Tenofovir alafenamide Viatris, emtricitabine,tenofovir alafenamide, Date of authorisation: 18/07/2025, Revision: 1, Status: Authorised

Q&A clinic on Substance, Organisation, Referentials Management Services - June 2026, Online, from 10 June 2026, 15:30 (CEST) to 10 June 2026, 16:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - July 2026, Online, from 8 July 2026, 15:30 (CEST) to 8 July 2026, 16:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - September 2026, Online, from 9 September 2026, 15:30 (CEST) to 9 September 2026, 16:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - October 2026, Online, from 7 October 2026, 15:30 (CEST) to 7 October 2026, 16:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - November 2026, Online, from 11 November 2026, 15:30 (CET) to 11 November 2026, 16:00 (CET)

Q&A clinic on Substance, Organisation, Referentials Management Services - December 2026, Online, from 9 December 2026, 15:30 (CET) to 9 December 2026, 16:00 (CET)

Q&A clinic on Substance, Organisation, Referentials Management Services - June, Online, from 10 June 2026, 15:30 (CEST) to 10 June 2026, 16:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - July, Online, from 8 July 2026, 15:30 (CEST) to 8 July 2026, 16:00 (CEST)